| Autonomy rules OK S Devaney Med. L. Rev. 13, 102, 2005 | 43* | 2005 |
| No-fault compensation schemes for medical injury: A review AM Farrell, S Devaney, A Dar Available at SSRN 2221836, 2010 | 33 | 2010 |
| Making amends or making things worse? Clinical negligence reform and patient redress in England AM Farrell, S Devaney Legal Studies 27 (4), 630-648, 2007 | 20 | 2007 |
| Can real-world data and rapid learning drive improvements in lung cancer survival? The RAPID-RT study G Price, S Devaney, DP French, R Holley, S Holm, E Kontopantelis, ... Clinical Oncology 34 (6), 407-410, 2022 | 16 | 2022 |
| Should doctors tackling covid-19 be immune from negligence liability claims? C Tomkins, C Purshouse, R Heywood, J Miola, E Cave, S Devaney bmj 370, 2020 | 15 | 2020 |
| Stem cell research and the collaborative regulation of innovation S Devaney Routledge, 2013 | 14 | 2013 |
| Gaps and overlaps: improving the current regulation of stem cells in the UK L Bell, S Devaney Journal of medical ethics 33 (11), 621-622, 2007 | 13 | 2007 |
| The transmutation of deference in medicine: An ethico-legal perspective S Devaney, S Holm Medical Law Review 26 (2), 202-224, 2018 | 12 | 2018 |
| Regulate to innovate: principles-based regulation of stem cell research S Devaney Medical Law International 11 (1), 53-68, 2011 | 11 | 2011 |
| The Transmutation of Deference in Medicine: An Ethico-Legal Perspective’(2018) S Devaney, S Holm Medical Law Review 26, 202, 0 | 11 | |
| The far-reaching implications of Montgomery for risk disclosure in practice S Devaney, C Purshouse, E Cave, R Heywood, J Miola, N Reinach Journal of Patient Safety and Risk Management 24 (1), 25-29, 2019 | 10 | 2019 |
| Improving healthcare through the use of ‘medical manslaughter’? Facts, fears and the future M Brazier, S Devaney, D Griffiths, A Mullock, H Quirk Clinical Risk 22 (5-6), 88-93, 2016 | 9 | 2016 |
| Pioneering healthcare law: essays in honour of Margaret Brazier C Stanton, S Devaney, AM Farrell, A Mullock Routledge, 2015 | 8 | 2015 |
| Non-Fungible Tokens as a mechanism for representing patient consent J Cunningham, N Davies, S Devaney, S Holm, M Harding, V Neumann, ... Challenges of Trustable AI and Added-Value on Health, 382-386, 2022 | 7 | 2022 |
| Rewards and incentives for the provision of human tissue for research S Devaney Journal of Medical Ethics 40 (1), 48-50, 2014 | 7 | 2014 |
| BALANCING DUTIES TO THE COURT AND CLIENT: THE REMOVAL OF IMMUNITY FROM SUIT OF EXPERT WITNESSES: JONES V KANEY [2011] UKSC 13 S Devaney Medical law review 20 (3), 450-459, 2012 | 5 | 2012 |
| Tissue providers for stem cell research: the dispossessed S Devaney Law, Innovation and Technology 2 (2), 165-191, 2010 | 5 | 2010 |
| REGULATORY ‘DESIRABLES’FOR NEW HEALTH TECHNOLOGIES AM Farrell, S Devaney, TK Hervey, T Murphy Medical law review 21 (1), 1-10, 2013 | 4 | 2013 |
| Breaches in good regulatory practice–the HFEA policy on compensated egg sharing for stem cell research S Devaney Clinical Ethics 3 (1), 20-24, 2008 | 4 | 2008 |
| Examining public views on decentralised health data sharing V Neumann, G Davidge, M Harding, J Cunningham, N Davies, S Devaney, ... Plos one 18 (3), e0282257, 2023 | 3 | 2023 |
